Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauro Gacci

Showing results (241-250 of 253) with videos related to

Pageof 26
Sort By:
Minerva Urology and Nephrology|November 17, 2020
The waiting time for prostate cancer treatment in Italy: analysis from the PROS-IT CNR StudyMauro Gacci, Isabella Greco, Walter Artibani, et al.
Minerva Urology and Nephrology|February 16, 2026
Accuracy, readability, and understandability of EAU Guidelines Bot for urinary infections guidelinesManfredi B Sequi, Riccardo Lombardo, Ludovica M Coppola, et al.
European Urology Oncology|October 8, 2025
Treatment Trajectories in Metastatic Hormone-sensitive Prostate Cancer: A PIONEER+ Big Data AnalysisRossella Nicoletti, Alex Qinyang Liu, Susan Evans-Axelsson, et al.
European Urology Open Science|October 23, 2025
Real-world Evidence on Baseline Characteristics and Treatment in Metastatic Hormone-sensitive Prostate Cancer: Findings from the PIONEER 2.0 Big Data Investigation GroupJuan Gómez Rivas, Pia Kraft, Susan Evans-Axelsson, et al.
European Urology Oncology|December 31, 2025
Corrigendum to "Treatment Trajectories in Metastatic Hormone-sensitive Prostate Cancer: A PIONEER+ Big Data Analysis" [Eur. Urol. Oncol. 8(5) (2025) 1340-1349]Rossella Nicoletti, Alex Qinyang Liu, Susan Evans-Axelsson, et al.
The Journal of Sexual Medicine|March 16, 2026
Accuracy, readability, and understandability of European Association of Urology guidelines bot for Sexual and Reproductive Health GuidelinesValerio Santarelli, Riccardo Lombardo, Matteo Romagnoli, et al.
World Journal of Urology|June 8, 2025
Minimally invasive surgical techniques (MISTs) for benign prostatic hyperplasia: results from a Delphi consensus project to shed light on controversial topicsFederica Passarelli, Daniele Castellani, Silvia Secco, et al.
BMJ Open|April 5, 2022
Diagnostic and prognostic factors in patients with prostate cancer: a systematic reviewKatharina Beyer, Lisa Moris, Michael Lardas, et al.
World Journal of Urology|August 3, 2020
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR studyMauro Gacci, Walter Artibani, Pierfrancesco Bassi, et al.
Minerva Urology and Nephrology|August 5, 2020
Enzalutamide in patients with castration-resistant prostate cancer: retrospective, multicenter, real life studyMauro Gacci, Michele Marchioni, Piergustavo DE Francesco, et al.
Pageof 26

Showing results (241-250 of 253) with videos related to

Sort By:
Pageof 26
Minerva Urology and Nephrology|November 17, 2020
The waiting time for prostate cancer treatment in Italy: analysis from the PROS-IT CNR StudyMauro Gacci, Isabella Greco, Walter Artibani, et al.
Minerva Urology and Nephrology|February 16, 2026
Accuracy, readability, and understandability of EAU Guidelines Bot for urinary infections guidelinesManfredi B Sequi, Riccardo Lombardo, Ludovica M Coppola, et al.
European Urology Oncology|October 8, 2025
Treatment Trajectories in Metastatic Hormone-sensitive Prostate Cancer: A PIONEER+ Big Data AnalysisRossella Nicoletti, Alex Qinyang Liu, Susan Evans-Axelsson, et al.
European Urology Open Science|October 23, 2025
Real-world Evidence on Baseline Characteristics and Treatment in Metastatic Hormone-sensitive Prostate Cancer: Findings from the PIONEER 2.0 Big Data Investigation GroupJuan Gómez Rivas, Pia Kraft, Susan Evans-Axelsson, et al.
European Urology Oncology|December 31, 2025
Corrigendum to "Treatment Trajectories in Metastatic Hormone-sensitive Prostate Cancer: A PIONEER+ Big Data Analysis" [Eur. Urol. Oncol. 8(5) (2025) 1340-1349]Rossella Nicoletti, Alex Qinyang Liu, Susan Evans-Axelsson, et al.
The Journal of Sexual Medicine|March 16, 2026
Accuracy, readability, and understandability of European Association of Urology guidelines bot for Sexual and Reproductive Health GuidelinesValerio Santarelli, Riccardo Lombardo, Matteo Romagnoli, et al.
World Journal of Urology|June 8, 2025
Minimally invasive surgical techniques (MISTs) for benign prostatic hyperplasia: results from a Delphi consensus project to shed light on controversial topicsFederica Passarelli, Daniele Castellani, Silvia Secco, et al.
BMJ Open|April 5, 2022
Diagnostic and prognostic factors in patients with prostate cancer: a systematic reviewKatharina Beyer, Lisa Moris, Michael Lardas, et al.
World Journal of Urology|August 3, 2020
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR studyMauro Gacci, Walter Artibani, Pierfrancesco Bassi, et al.
Minerva Urology and Nephrology|August 5, 2020
Enzalutamide in patients with castration-resistant prostate cancer: retrospective, multicenter, real life studyMauro Gacci, Michele Marchioni, Piergustavo DE Francesco, et al.
Pageof 26